GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
GoodRx (GDRX) has launched 'GoodRx for Pets,' a new platform offering savings and home delivery for pet medications. The service aims to address the rising cost of pet healthcare, which saw Americans spend over $13 billion on pet medications in 2023. With pet care prices increasing 25% in the last five years and only 3% of pets having insurance coverage, the platform offers up to 80% savings on medications at over 70,000 retail pharmacies nationwide.
The new service, powered by Allivet, includes an integrated e-commerce experience for direct-to-door delivery and access to pet-specific medications not available in retail pharmacies. The platform also provides expert-created educational content on pet health. GoodRx reports that pet owners have already been using their platform for millions of prescriptions annually, prompting this dedicated pet-focused expansion.
GoodRx (GDRX) ha lanciato 'GoodRx for Pets', una nuova piattaforma che offre risparmi e consegna a domicilio per i farmaci per animali domestici. Il servizio mira a affrontare l'aumento dei costi per la salute degli animali, con oltre 13 miliardi di dollari spesi dagli americani per i farmaci per animali nel 2023. Con i prezzi delle cure per animali in aumento del 25% negli ultimi cinque anni e solo 3% degli animali coperti da assicurazione, la piattaforma offre fino a 80% di risparmio sui farmaci in oltre 70.000 farmacie al dettaglio negli Stati Uniti.
Il nuovo servizio, supportato da Allivet, include un'esperienza e-commerce integrata per consegne a domicilio e accesso a farmaci specifici per animali non disponibili nelle farmacie al dettaglio. La piattaforma fornisce anche contenuti educativi creati da esperti sulla salute degli animali. GoodRx riporta che i proprietari di animali hanno già utilizzato la loro piattaforma per milioni di prescrizioni all'anno, dando origine a questa espansione dedicata agli animali domestici.
GoodRx (GDRX) ha lanzado 'GoodRx for Pets', una nueva plataforma que ofrece ahorros y entrega a domicilio para medicamentos para mascotas. El servicio tiene como objetivo abordar el aumento del costo de la atención médica para mascotas, que vio a los estadounidenses gastar más de $13 mil millones en medicamentos para mascotas en 2023. Con los precios de atención para mascotas aumentando 25% en los últimos cinco años y solo 3% de las mascotas teniendo cobertura de seguro, la plataforma ofrece hasta un 80% de ahorro en medicamentos en más de 70,000 farmacias al por menor en todo el país.
El nuevo servicio, impulsado por Allivet, incluye una experiencia de comercio electrónico integrada para entrega a domicilio y acceso a medicamentos específicos para mascotas que no están disponibles en farmacias al por menor. La plataforma también proporciona contenido educativo creado por expertos sobre la salud de las mascotas. GoodRx informa que los dueños de mascotas ya han estado utilizando su plataforma para millones de recetas anualmente, lo que ha llevado a esta expansión enfocada en las mascotas.
GoodRx (GDRX)는 반려동물 의약품에 대한 절약 및 가정 배달 서비스를 제공하는 새로운 플랫폼인 'GoodRx for Pets'를 출시했습니다. 이 서비스는 2023년에 미국인이 반려동물 의약품에 대해 130억 달러 이상을 지출한 점을 고려하여 반려동물 건강관리 비용 상승 문제를 해결하고자 합니다. 반려동물 치료 비용이 지난 5년간 25% 증가하고, 반려동물 중 3%만이 보험에 가입되어 있는 상황에서, 이 플랫폼은 전국의 70,000개 이상의 소매 약국에서 의약품에 대해 최대 80% 절약 혜택을 제공합니다.
Allivet이 지원하는 이 새로운 서비스는 문 앞까지 직접 배송을 위한 통합 전자 상거래 경험과 소매 약국에서 구입할 수 없는 반려동물 전용 의약품에 대한 접근을 포함합니다. 또한 이 플랫폼은 반려동물 건강에 관한 전문가가 만든 교육 콘텐츠를 제공합니다. GoodRx는 반려동물 소유자들이 매년 수백만 개의 처방전을 이용하고 있다고 보고하며, 이를 계기로 반려동물 전문 서비스를 확장하게 되었습니다.
GoodRx (GDRX) a lancé 'GoodRx for Pets', une nouvelle plateforme offrant des économies et une livraison à domicile pour les médicaments pour animaux. Ce service vise à répondre à la hausse des coûts des soins vétérinaires, avec plus de 13 milliards de dollars dépensés par les Américains en médicaments pour animaux en 2023. Les prix des soins pour animaux ayant augmenté de 25% au cours des cinq dernières années et seulement 3% des animaux ayant une couverture d'assurance, la plateforme propose jusqu'à 80% d'économies sur les médicaments dans plus de 70 000 pharmacies de détail à travers le pays.
Le nouveau service, soutenu par Allivet, comprend une expérience e-commerce intégrée pour la livraison directement à la porte et un accès à des médicaments spécifiques aux animaux non disponibles dans les pharmacies de détail. La plateforme fournit également du contenu éducatif créé par des experts sur la santé des animaux. GoodRx rapporte que les propriétaires d'animaux ont déjà utilisé leur plateforme pour des millions d'ordonnances par an, entraînant cette expansion dédiée aux animaux.
GoodRx (GDRX) hat 'GoodRx for Pets' gestartet, eine neue Plattform, die Einsparungen und Hauslieferung für Tiermedikamente bietet. Der Dienst zielt darauf ab, die steigenden Gesundheitskosten für Haustiere zu adressieren, bei denen Amerikaner 2023 über 13 Milliarden Dollar für Tiermedikamente ausgaben. Da die Preise für Tierpflege in den letzten fünf Jahren um 25% gestiegen sind und nur 3% der Haustiere eine Versicherungsdeckung haben, bietet die Plattform Einsparungen von bis zu 80% für Medikamente in über 70.000 Einzelhandelsapotheken im ganzen Land.
Der neue Service, unterstützt von Allivet, umfasst ein integriertes E-Commerce-Erlebnis für die Lieferung direkt an die Tür und den Zugang zu tierartspezifischen Medikamenten, die in Einzelhandelsapotheken nicht erhältlich sind. Die Plattform bietet auch von Experten erstellte Bildungsinhalte zur Haustiergesundheit. GoodRx berichtet, dass Haustierbesitzer ihre Plattform bereits für Millionen von Rezepten jährlich nutzen, was zu dieser dedizierten, auf Haustiere fokussierten Expansion führte.
- Launch of new revenue stream through pet medication market
- Access to $13 billion pet medication market
- Integration with 70,000+ retail pharmacies
- New e-commerce capabilities through Allivet partnership
- Potential for up to 80% cost savings for customers
- None.
Insights
The launch of GoodRx for Pets represents a strategic expansion into the $13 billion pet medication market, addressing a critical gap in the pet healthcare sector. With pet care costs surging
The timing is particularly strategic given the accelerating trend of pet humanization and increasing pet healthcare spending. By offering savings up to
From a revenue perspective, this expansion could significantly impact GoodRx's financials. With several million pet prescriptions already being processed annually through their platform without active marketing, the formalized pet-focused service could drive substantial growth. The e-commerce integration introduces a new revenue model beyond traditional prescription discount cards, potentially improving profit margins through direct-to-consumer sales.
The partnership with Allivet demonstrates GoodRx's ability to leverage its existing technology infrastructure while minimizing capital expenditure. This asset-light approach to entering the pet medication market could yield attractive returns on investment. The move also diversifies revenue streams and reduces dependency on human prescription services, potentially leading to multiple expansion if successful.
GoodRx for Pets leverages new integrated e-commerce capabilities to create a seamless user experience for accessing essential pet medications and information
GoodRx for Pets (Graphic: Business Wire)
The rising cost of pet healthcare is a significant concern for many Americans, who collectively spent more than
With GoodRx for Pets, pet parents can now:
-
Find savings on pet medications: Using GoodRx, pet owners can save up to
80% on medications for themselves and their pets, including pet medications for common pet conditions like allergies, anxiety, diabetes, pain, and seizures that are available at more than 70,000 retail pharmacies nationwide. - Skip the trip to the pharmacy: GoodRx now offers an integrated e-commerce experience, powered by Allivet, that allows pet owners to order medications and have them delivered right to their door. For the first time, GoodRx users can access pet-specific medications that aren’t available in retail pharmacies via the platform.
- Keep up with your pet’s health: GoodRx offers expert-created articles and videos on pet health so you can get the best care for your dogs, cats, and other pets.
"Pet owners have been using GoodRx for years to save on medications for their beloved pets for conditions like anxiety and seizures - to the tune of several million prescriptions per year,” said Aaron Crittenden, SVP of Rx Marketplace at GoodRx. “It's a pretty strong signal of value when people use your platform for something you haven't actively pursued. So, we decided to build a focused experience for pet owners with a broader range of medications, more savings, and easy access through both pharmacies and home delivery. We're excited about what GoodRx for Pets can do for American households over time."
GoodRx for Pets leverages the company’s newly-launched e-commerce capability, which enables consumer health and pharmaceutical brands looking to provide a frictionless experience for consumers to integrate their offerings directly into the GoodRx platform.
To learn more about GoodRx for Pets and start saving, visit www.goodrx.com/pets
About GoodRx
GoodRx is the leading prescription savings platform in the
GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission (the “SEC”) and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated consumer savings, convenience and accessibility; the expected benefits and value of our GoodRx for Pets offering and partnership with Allivet; and our plans, expectations and objectives. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, risks relating to our ability to achieve broad market education and change consumer purchasing habits; changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023, and our other filings with the SEC. Any such forward-looking statements are based on current expectations, projections and estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250107996835/en/
Source: GoodRx
FAQ
What savings does GoodRx for Pets (GDRX) offer on pet medications?
How large is the pet medication market that GoodRx (GDRX) is entering in 2024?
What delivery options does GoodRx for Pets (GDRX) provide?
Which pharmacies accept GoodRx for Pets (GDRX) prescriptions?
What types of pet medications does GoodRx (GDRX) cover?
